DK0486666T3 - Terapeutisk heterocykliske forbindelser - Google Patents
Terapeutisk heterocykliske forbindelserInfo
- Publication number
- DK0486666T3 DK0486666T3 DK91911486.8T DK91911486T DK0486666T3 DK 0486666 T3 DK0486666 T3 DK 0486666T3 DK 91911486 T DK91911486 T DK 91911486T DK 0486666 T3 DK0486666 T3 DK 0486666T3
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- heterocyclic compounds
- alkyl
- therapeutic heterocyclic
- therapeutic
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Steroid Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909012672A GB9012672D0 (en) | 1990-06-07 | 1990-06-07 | Therapeutic heterocyclic compounds |
GB919102182A GB9102182D0 (en) | 1991-02-01 | 1991-02-01 | Therapeutic heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0486666T3 true DK0486666T3 (da) | 1998-03-30 |
Family
ID=26297174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91911486.8T DK0486666T3 (da) | 1990-06-07 | 1991-06-06 | Terapeutisk heterocykliske forbindelser |
Country Status (37)
Country | Link |
---|---|
US (3) | US5399574A (uk) |
EP (2) | EP0636623B1 (uk) |
JP (1) | JP2738461B2 (uk) |
KR (1) | KR100215627B1 (uk) |
AT (2) | ATE204275T1 (uk) |
AU (1) | AU646871B2 (uk) |
CA (2) | CA2064815C (uk) |
CZ (1) | CZ288351B6 (uk) |
DE (3) | DE69132691T2 (uk) |
DK (1) | DK0486666T3 (uk) |
EG (1) | EG19650A (uk) |
ES (1) | ES2104708T3 (uk) |
FI (3) | FI105686B (uk) |
GR (1) | GR3024828T3 (uk) |
HK (1) | HK1000534A1 (uk) |
HR (1) | HRP940524B1 (uk) |
HU (2) | HU219974B (uk) |
IE (1) | IE911931A1 (uk) |
IL (3) | IL98392A (uk) |
LT (1) | LT3264B (uk) |
LU (1) | LU90205I2 (uk) |
LV (1) | LV10274B (uk) |
MC (1) | MC2210A1 (uk) |
MX (1) | MX9203421A (uk) |
MY (1) | MY110226A (uk) |
NL (1) | NL980001I2 (uk) |
NO (2) | NO300634B1 (uk) |
NZ (1) | NZ238424A (uk) |
PL (1) | PL166214B1 (uk) |
PT (1) | PT97888B (uk) |
RU (1) | RU2160736C2 (uk) |
SA (1) | SA05260104B1 (uk) |
SI (2) | SI21560B (uk) |
SK (1) | SK281621B6 (uk) |
UA (1) | UA37178C2 (uk) |
WO (1) | WO1991018897A1 (uk) |
YU (1) | YU48855B (uk) |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
TW263508B (uk) * | 1991-02-12 | 1995-11-21 | Pfizer | |
EP0619805B1 (en) * | 1991-11-25 | 2000-03-15 | Pfizer Inc. | 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists |
GB9201038D0 (en) * | 1992-01-16 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
TW288010B (uk) * | 1992-03-05 | 1996-10-11 | Pfizer | |
CA2129146A1 (en) * | 1992-03-13 | 1993-09-16 | Victor Giulio Matassa | Imidazole, triazole and tetrazole derivatives |
GB9207396D0 (en) * | 1992-04-03 | 1992-05-13 | Merck Sharp & Dohme | Therapeutic agents |
US6380233B1 (en) | 1992-04-07 | 2002-04-30 | Pfizer Inc | Indole derivatives as 5-HT1 agonists |
US5747501A (en) * | 1992-04-07 | 1998-05-05 | Pfizer, Inc. | Indole derivatives |
UA34452C2 (uk) * | 1992-04-10 | 2001-03-15 | Пфайзер Інк. | Похідні ациламіноіндолу, що проявляють серотонінову 5-нт1 агоністичну активність та похідні аміноіндолу як проміжні сполуки |
GB9207930D0 (en) * | 1992-04-10 | 1992-05-27 | Pfizer Ltd | Indoles |
GB9208161D0 (en) * | 1992-04-14 | 1992-05-27 | Pfizer Ltd | Indoles |
GB9208463D0 (en) * | 1992-04-16 | 1992-06-03 | Merck Sharp & Dohme | Therapeutic agents |
GB9209882D0 (en) * | 1992-05-07 | 1992-06-24 | Glaxo Lab Sa | Compositions |
GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
AU672802B2 (en) * | 1992-07-24 | 1996-10-17 | Merck Sharp & Dohme Limited | Imidazole, triazole and tetrazole derivatives |
GB9216009D0 (en) * | 1992-07-28 | 1992-09-09 | Almirall Lab | New indol derivatives |
IL106445A (en) * | 1992-07-30 | 1998-01-04 | Merck Sharp & Dohme | History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them |
ES2056025B1 (es) * | 1992-10-08 | 1995-05-01 | Almirall Lab | Nuevos derivados de indol. |
TW251284B (uk) * | 1992-11-02 | 1995-07-11 | Pfizer | |
GB9226532D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
FR2701026B1 (fr) * | 1993-02-02 | 1995-03-31 | Adir | Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
ES2070087B1 (es) * | 1993-08-13 | 1996-02-16 | Pfizer | Derivados de indol |
CZ59996A3 (en) * | 1993-08-31 | 1996-06-12 | Pfizer | 5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon |
US6423731B2 (en) | 1994-01-06 | 2002-07-23 | Zeneca Limited | Indole derivatives as prodrugs of 5-HT1-like receptor agonists |
US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
GB9401436D0 (en) * | 1994-01-26 | 1994-03-23 | Wellcome Found | Therapeutic heterocyclic compounds |
AU694226B2 (en) * | 1994-05-19 | 1998-07-16 | Merck Sharp & Dohme Limited | Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists |
ES2161892T3 (es) * | 1994-06-01 | 2001-12-16 | Astrazeneca Ab | Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1. |
CA2194984C (en) * | 1994-07-26 | 2002-07-02 | John Eugene Macor | 4-indole derivatives as serotonin agonists and antagonists |
US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
GB9423682D0 (en) * | 1994-11-23 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
CA2207201A1 (en) * | 1994-12-06 | 1996-06-13 | Caroline Henry | Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
DE4443892A1 (de) * | 1994-12-09 | 1996-06-13 | Bayer Ag | 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate |
GB9501865D0 (en) * | 1995-01-31 | 1995-03-22 | Merck Sharp & Dohme | Therapeutic agents |
JPH11502816A (ja) * | 1995-03-20 | 1999-03-09 | イーライ・リリー・アンド・カンパニー | 5−置換−3−(1,2,3,6−テトラヒドロピリジン−4−イル)−および3−(ピペリジン−4−イル)−1h−インドール類:新規5−ht▲下1f▼アゴニスト |
GB9515060D0 (en) * | 1995-07-22 | 1995-09-20 | Wellcome Found | Therapeutic heterocyclic compounds |
GB9515305D0 (en) * | 1995-07-26 | 1995-09-20 | Wellcome Found | Therapeutic heterocyclic compounds |
US6909005B1 (en) * | 1995-08-07 | 2005-06-21 | Astrazeneca Uk Limited | One post synthesis of 2-oxazolidinone derivatives |
GB9516143D0 (en) | 1995-08-07 | 1995-10-04 | Wellcome Found | Improved chemical synthesis |
GB9516145D0 (en) * | 1995-08-07 | 1995-10-04 | Wellcome Found | Improved chemical synthesis |
JPH11513666A (ja) * | 1995-10-10 | 1999-11-24 | イーライ・リリー・アンド・カンパニー | N−[2−置換−3−(2−アミノエチル)−1h−インドール−5−イル]−アミド:新規5−ht▲下1f▼作動剤 |
WO1997016446A1 (en) * | 1995-11-02 | 1997-05-09 | Merck Sharp & Dohme Limited | Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation and their use as selective agonists of 5-ht1-like receptors |
GB9609374D0 (en) * | 1996-05-03 | 1996-07-10 | Merck Sharp & Dohme | Therapeutic agents |
US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
GB9706089D0 (en) | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US6066092A (en) * | 1997-11-06 | 2000-05-23 | Cady; Roger K. | Preemptive prophylaxis of migraine device and method |
AR017200A1 (es) | 1997-12-23 | 2001-08-22 | Astrazeneca Ab | Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos |
SE9800835D0 (sv) | 1998-03-13 | 1998-03-13 | Astra Ab | New Compounds |
WO2000000490A2 (en) * | 1998-06-26 | 2000-01-06 | Eli Lilly And Company | 5-ht1f agonists |
US6492406B1 (en) | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
US6346625B1 (en) * | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
GB9928578D0 (en) * | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Pharmaceutical formulations |
WO2002044159A2 (en) * | 2000-11-29 | 2002-06-06 | Eli Lilly And Company | 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
US20070122353A1 (en) * | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US7458374B2 (en) * | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US20030013753A1 (en) * | 2001-06-05 | 2003-01-16 | Ronald Aung-Din | Transdermal migraine therapy |
US8329734B2 (en) | 2009-07-27 | 2012-12-11 | Afgin Pharma Llc | Topical therapy for migraine |
US20030198669A1 (en) * | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
US20030017175A1 (en) * | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
JP4625637B2 (ja) | 2002-02-22 | 2011-02-02 | シャイア エルエルシー | 活性物質送達系及び活性物質を保護し投与する方法 |
ATE444965T1 (de) | 2002-06-21 | 2009-10-15 | Suven Life Sciences Ltd | Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten |
RU2340619C2 (ru) | 2002-06-21 | 2008-12-10 | Сувен Лайф Сайенсиз Лимитед | Новые тетрациклические арилсульфонилиндолы с аффинностью к серотониновым рецепторам, пригодные в качестве лекарственных средств, способ их получения и содержащие их фармацевтические композиции |
ES2204302B2 (es) | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) * | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
CN102249981A (zh) | 2002-11-28 | 2011-11-23 | 苏文生命科学有限公司 | N-芳基磺酰基-3-氨基烷氧基吲哚 |
AU2003237599B2 (en) | 2002-11-28 | 2009-06-18 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
AU2003292510B2 (en) | 2002-12-18 | 2009-04-23 | Suven Life Sciences Limited | Tetracyclic 3-substituted indoles having serotonin receptor affinity |
EP2666772B1 (en) | 2002-12-20 | 2017-03-01 | Basf Se | Synthesis of amines and intermediates for the synthesis thereof |
WO2004063175A1 (en) * | 2003-01-13 | 2004-07-29 | Natco Pharma Limited | A novel and an improved process for the preparation of (s)-4-(4-aminobenzyl)-2- oxazolidinone |
GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
US20040192958A1 (en) * | 2003-03-25 | 2004-09-30 | Hyatt John Anthony | Process for preparing derivatives of 4-halobutyraldehyde |
EP1625333A1 (en) | 2003-05-21 | 2006-02-15 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
MY142655A (en) * | 2003-06-12 | 2010-12-15 | Euro Celtique Sa | Therapeutic agents useful for treating pain |
US20070065463A1 (en) * | 2003-06-20 | 2007-03-22 | Ronald Aung-Din | Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions |
BRPI0412808A (pt) * | 2003-07-24 | 2006-09-26 | Euro Celtique Sa | compostos de piperidina e composições farmacêuticas contendo os mesmos |
GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
WO2005075467A2 (en) * | 2004-02-06 | 2005-08-18 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of zolmitriptan |
US7540286B2 (en) * | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
AU2004322756B2 (en) * | 2004-08-12 | 2011-04-14 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
US20060211751A1 (en) * | 2004-11-19 | 2006-09-21 | Reuven Izsak | Zolmitriptan crystal forms |
KR20130136010A (ko) | 2005-04-13 | 2013-12-11 | 네우렉슨 인코포레이티드 | Nos 저해 활성을 갖는 치환된 인돌 화합물 |
ATE510836T1 (de) | 2006-01-19 | 2011-06-15 | Matrix Lab Ltd | Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin |
EP2010527B1 (en) | 2006-04-13 | 2013-08-14 | Neuraxon Inc. | 1,5 and 3,6- substituted indole compounds having nos inhibitory activity |
WO2008018090A2 (en) * | 2006-08-09 | 2008-02-14 | Matrix Laboratories Ltd | An improved process for the preparation of zolmitriptan |
AU2007310949A1 (en) * | 2006-10-19 | 2008-04-24 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
AU2008214205B2 (en) * | 2007-02-11 | 2014-04-24 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
CZ2007158A3 (cs) * | 2007-02-26 | 2008-10-22 | Zentiva, A. S. | Zpusob prípravy zolmitriptanu |
ES2594867T3 (es) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Unidad de calentamiento para usar en un dispositivo de administración de fármaco |
MY148657A (en) * | 2007-04-27 | 2013-05-15 | Purdue Pharma Lp | Trpv1 antagonists and uses thereof |
NZ579820A (en) * | 2007-04-27 | 2011-01-28 | Purdue Pharma Lp | Therapeutic agents useful for treating pain |
WO2009044211A1 (en) * | 2007-10-03 | 2009-04-09 | Generics [Uk] Limited | Process for the preparation of zolmitriptan, salts and solvates thereof |
WO2009062319A1 (en) | 2007-11-16 | 2009-05-22 | Neuraxon, Inc. | Indole compounds and methods for treating visceral pain |
US20090163451A1 (en) * | 2007-11-16 | 2009-06-25 | Frank Porreca | Methods for treating visceral pain |
MX2010005343A (es) * | 2007-11-16 | 2010-08-09 | Neuraxon Inc | Compuestos indola 3, 5-sustituidos que tienen actividad inhibidora de la re-absorcion y el reciclo de nos y norepinefrina. |
CN101181267B (zh) * | 2007-11-30 | 2010-09-08 | 重庆医科大学医药研究所 | 佐米曲普坦舌下片 |
KR101517415B1 (ko) * | 2008-05-14 | 2015-05-07 | 에스케이바이오팜 주식회사 | 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물 |
JP2011526889A (ja) | 2008-06-30 | 2011-10-20 | アフギン ファーマ,エルエルシー | 局所局部的神経作用療法 |
US20100217013A1 (en) * | 2008-12-15 | 2010-08-26 | Wenge Li | Enantioselective process for the preparation of zolmitriptan |
WO2010151804A1 (en) * | 2009-06-26 | 2010-12-29 | Map Pharmaceuticals, Inc. | Administration of dihydroergotamine mesylate particles using a metered dose inhaler |
US20110038928A1 (en) * | 2009-08-12 | 2011-02-17 | Glenmark Generics Ltd | Orally disintegrating tablets of zolmitriptan |
CA2813648C (en) | 2010-10-15 | 2019-06-25 | Concit Pharma Aps | Combinations of serotonin receptor agonists for treatment of movement disorders |
ME02609B (me) | 2011-06-22 | 2017-06-20 | Purdue Pharma Lp | TRPV1 ANTAGONISTI KOJI UKLJUČUJU DIHIDROKSI SUPSTITUENT l NJIHOVE UPOTREBE |
AU2012287120B2 (en) | 2011-07-22 | 2017-02-23 | The University Of Chicago | Treatments for migraine and related disorders |
US9006453B2 (en) | 2011-09-02 | 2015-04-14 | Emcure Pharmaceuticals Limited | Process for preparation of zolmitriptan |
NO2838517T3 (uk) | 2012-04-18 | 2018-03-17 | ||
US9394314B2 (en) | 2012-12-21 | 2016-07-19 | Map Pharmaceuticals, Inc. | 8′-hydroxy-dihydroergotamine compounds and compositions |
US10383816B2 (en) | 2015-03-02 | 2019-08-20 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoid combination products |
BR112017018944A2 (pt) | 2015-03-02 | 2018-05-15 | Afgin Pharma Llc | método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s) |
WO2017122161A1 (en) | 2016-01-15 | 2017-07-20 | Cadila Healthcare Limited | An intranasal composition comprising 5ht1b/1d receptor agonists |
EP3407869A1 (en) | 2016-01-27 | 2018-12-05 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
WO2018011181A1 (en) | 2016-07-11 | 2018-01-18 | Contera Pharma Aps | Pulsatile drug delivery system for treating morning akinesia |
US20180049994A1 (en) | 2016-08-16 | 2018-02-22 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with caryophyllene |
WO2020249802A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyrazines and their use as glun2b receptor modulators |
EP3766483A1 (en) | 2019-07-19 | 2021-01-20 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising a triptan |
US20210322343A1 (en) | 2020-04-15 | 2021-10-21 | Farzana Shaheen | Nasally administered pharmaceutical composition for the treatment of epilepsy and related disorders |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB148879A (en) * | 1919-02-14 | 1921-11-10 | Emil Vincance Noser | Locks for shift levers of automobiles |
US3320282A (en) * | 1962-10-29 | 1967-05-16 | Pfizer & Co C | Process for preparing esters of 2-hydroxy-3-(3-indolyl) alkanoic acids |
US3879410A (en) * | 1971-02-08 | 1975-04-22 | Messrs Lab Guidotti & C S P A | 4-Aryl-4-oxazolin-2-ones exhibiting myotonic and myorelaxing activity |
BE795457A (fr) * | 1972-02-16 | 1973-08-16 | Clin Midy | Amines indoliques, leur preparation et leur application en therapeutiques |
FR2179582B1 (uk) * | 1972-04-13 | 1975-10-10 | Synthelabo | |
US3873559A (en) * | 1973-03-30 | 1975-03-25 | Squibb & Sons Inc | Heterocyclic carboxamido thiazolinyl indoles |
IT995110B (it) * | 1973-08-01 | 1975-11-10 | Snam Progetti | Procedimento per la produzione di composti eterociclici e prodotti ottenuti |
US4042595A (en) * | 1973-08-01 | 1977-08-16 | Snam Progetti S.P.A. | Processes for the production of heterocyclic compounds |
US3931229A (en) * | 1973-08-23 | 1976-01-06 | Warner-Lambert Company | 3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles |
US4049816A (en) * | 1975-03-24 | 1977-09-20 | Beecham Group Limited | Antiviral 2-amino-5-[1-(indol-3-yl)alkyl]-2-thiazolin-4-ones |
US4062862A (en) * | 1975-07-04 | 1977-12-13 | Nippon Chemiphar Co., Ltd. | 5-Benzyl-2-oxazolidone derivatives and a process for producing the same |
GB1482879A (en) * | 1975-07-24 | 1977-08-17 | Nippon Chemiphar Co | 5-benzyl-2-oxazolidone derivatives and a process for producing the same |
GB1469200A (en) * | 1975-11-28 | 1977-03-30 | Warner Lambert Co | 3-thiomethyl-2-2-dialkylamino-ethyl-indoles |
DE2557341A1 (de) * | 1975-12-19 | 1977-06-30 | Hoechst Ag | Basisch substituierte indolderivate und verfahren zu ihrer herstellung |
IT1109002B (it) * | 1977-09-22 | 1985-12-16 | Menarini Sas | Derivati del 2 oxazolidone e loro metodi di preparazione |
US4137404A (en) * | 1977-12-20 | 1979-01-30 | Hoffmann-La Roche Inc. | Synthesis of tryptophans |
US4198501A (en) * | 1977-12-20 | 1980-04-15 | Hoffmann-La Roche Inc. | Synthesis of tryptophans |
JPS6014032B2 (ja) * | 1978-01-20 | 1985-04-11 | 日本ケミフア株式会社東京 | 5‐フエネチル‐2‐オキサゾリドン誘導体およびその製法 |
US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
DE2933636A1 (de) * | 1978-08-30 | 1980-03-20 | Sandoz Ag | Neue n-phenylindolinderivate, ihre herstellung und pharmazeutische praeparate, welche diese verbindungen enthalten |
ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
US4255432A (en) * | 1979-09-06 | 1981-03-10 | Syntex (U.S.A.) Inc. | 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof |
US4272555A (en) * | 1979-09-21 | 1981-06-09 | Monsanto Company | Conversion of carbon-containing materials to carbon monoxide |
DE3164982D1 (de) * | 1980-04-10 | 1984-08-30 | Sandoz Ag | Isoxazolyl indolamines |
JPS574986A (en) * | 1980-06-13 | 1982-01-11 | Paamakemu Asia:Kk | Preparation of oxazolidine derivative |
US4753956A (en) * | 1981-01-02 | 1988-06-28 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
US4367234A (en) * | 1980-07-28 | 1983-01-04 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
NZ197996A (en) * | 1980-08-12 | 1985-08-16 | Glaxo Group Ltd | 1-(3-(omega-aminoalkyl)-1h-indol-5-yl)alkanamides |
ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
ZA815541B (en) * | 1980-08-12 | 1983-03-30 | Glaxo Group Ltd | Heterocyclic compounds |
US4399296A (en) * | 1981-01-02 | 1983-08-16 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
US4407811A (en) * | 1981-01-02 | 1983-10-04 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
US4448971A (en) * | 1981-01-02 | 1984-05-15 | Pfizer Inc. | Hypoglycemic 5-phenyl-substituted oxazolidine-2,4-diones |
JPS57169458A (en) * | 1981-04-13 | 1982-10-19 | Paamakemu Asia:Kk | Preparation of indole derivative |
CH656124A5 (de) * | 1982-04-13 | 1986-06-13 | Sandoz Ag | 2-substituierte-3-indolamine, verfahren zu deren herstellung sowie deren verwendung. |
GR79215B (uk) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
US4803218A (en) * | 1982-09-29 | 1989-02-07 | Mcneilab, Inc. | 3-aminoalkyl-1H-indole-5-urea and amide derivatives |
US4500717A (en) * | 1983-03-28 | 1985-02-19 | The Dow Chemical Company | Process for preparation of 2-oxazolidinones |
US4831153A (en) * | 1983-06-27 | 1989-05-16 | The Dow Chemical Company | Preparation of N-vinyl-2-oxazolidinone |
GB8321813D0 (en) * | 1983-08-12 | 1983-09-14 | Vickers Plc | Radiation sensitive compounds |
DE3333450A1 (de) * | 1983-09-16 | 1985-04-11 | Hoechst Ag, 6230 Frankfurt | Trihalogenmethylgruppen enthaltende carbonylmethylenheterocyclen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt |
GB8332435D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
DE3430284A1 (de) * | 1984-08-17 | 1986-02-27 | Troponwerke GmbH & Co KG, 5000 Köln | Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung |
FR2574077A1 (fr) * | 1984-12-04 | 1986-06-06 | Glaxo Group Ltd | Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant |
GB8431426D0 (en) * | 1984-12-13 | 1985-01-23 | Glaxo Group Ltd | Chemical compounds |
DE3514696A1 (de) * | 1985-04-24 | 1986-11-06 | Bayer Ag, 5090 Leverkusen | N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung |
DE3531658A1 (de) * | 1985-09-05 | 1987-03-12 | Boehringer Mannheim Gmbh | Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel |
DE3678805D1 (de) * | 1985-11-08 | 1991-05-23 | Glaxo Group Ltd | Indolderivate. |
GB8531612D0 (en) * | 1985-12-23 | 1986-02-05 | Beecham Wuelfing Gmbh & Co Kg | Compounds |
SE451840B (sv) * | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning |
GB8600398D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
GB8600397D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
GB8607824D0 (en) * | 1986-03-27 | 1986-04-30 | Glaxo Group Ltd | Chemical compounds |
DE3643957A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | Substituierte n-methylisoxazolidine |
GB2208646B (en) * | 1987-08-13 | 1991-06-26 | Glaxo Group Ltd | Indole derivatives |
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
DE3730777A1 (de) * | 1987-09-12 | 1989-03-23 | Basf Ag | Verfahren zur herstellung von imidazolidinonen und oxazolidinonen |
US4965268A (en) * | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4921869A (en) * | 1987-10-09 | 1990-05-01 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
DE3823299A1 (de) * | 1988-07-07 | 1990-01-11 | Schering Ag | Substituierte phenyl-pyrrolidin-2-one, -oxazolidin-2-one und -imidazolidin-2-one, ihre herstellung sowie verwendung in arzneimitteln |
GB8819024D0 (en) * | 1988-08-10 | 1988-09-14 | Glaxo Group Ltd | Chemical compounds |
US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
DE68918792T2 (de) * | 1988-09-15 | 1995-03-30 | Upjohn Co | 5-Indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(Nitrogen-substituierte)phenyl-5-beta-amidomethyloxazolidin-2-one. |
DE3939238A1 (de) * | 1989-11-28 | 1991-05-29 | Bayer Ag | Heterocyclisch substituierte acrylsaeureester |
DE4013907A1 (de) * | 1990-04-26 | 1991-10-31 | Schering Ag | Verfahren zur herstellung von gramin-derivaten |
CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
GB9104136D0 (en) * | 1991-02-27 | 1991-04-17 | Merck Sharp & Dohme | Therapeutic agents |
US5409941A (en) * | 1992-02-03 | 1995-04-25 | Pfizer Inc. | 5-heteroyl indole derivatives |
-
1991
- 1991-06-06 SI SI9119001A patent/SI21560B/sl active Search and Examination
- 1991-06-06 DE DE69132691T patent/DE69132691T2/de not_active Expired - Lifetime
- 1991-06-06 AT AT94115107T patent/ATE204275T1/de active
- 1991-06-06 CA CA002064815A patent/CA2064815C/en not_active Expired - Lifetime
- 1991-06-06 EP EP94115107A patent/EP0636623B1/en not_active Expired - Lifetime
- 1991-06-06 US US07/838,233 patent/US5399574A/en not_active Expired - Lifetime
- 1991-06-06 EP EP91911486A patent/EP0486666B1/en not_active Expired - Lifetime
- 1991-06-06 ES ES91911486T patent/ES2104708T3/es not_active Expired - Lifetime
- 1991-06-06 MY MYPI91001002A patent/MY110226A/en unknown
- 1991-06-06 WO PCT/GB1991/000908 patent/WO1991018897A1/en active IP Right Grant
- 1991-06-06 NZ NZ238424A patent/NZ238424A/xx not_active IP Right Cessation
- 1991-06-06 IL IL9839291A patent/IL98392A/en not_active IP Right Cessation
- 1991-06-06 EG EG35491A patent/EG19650A/xx active
- 1991-06-06 DE DE1991627260 patent/DE19775091I2/de active Active
- 1991-06-06 JP JP3510103A patent/JP2738461B2/ja not_active Expired - Lifetime
- 1991-06-06 UA UA93002089A patent/UA37178C2/uk unknown
- 1991-06-06 CA CA002282890A patent/CA2282890C/en not_active Expired - Lifetime
- 1991-06-06 PT PT97888A patent/PT97888B/pt not_active IP Right Cessation
- 1991-06-06 DK DK91911486.8T patent/DK0486666T3/da active
- 1991-06-06 SK SK1727-91A patent/SK281621B6/sk not_active IP Right Cessation
- 1991-06-06 IE IE193191A patent/IE911931A1/en not_active IP Right Cessation
- 1991-06-06 AT AT91911486T patent/ATE156823T1/de active
- 1991-06-06 HU HU9200384A patent/HU219974B/hu unknown
- 1991-06-06 SI SI9111010A patent/SI9111010B/sl active Search and Examination
- 1991-06-06 AU AU79570/91A patent/AU646871B2/en not_active Expired
- 1991-06-06 IL IL11469091A patent/IL114690A/xx not_active IP Right Cessation
- 1991-06-06 RU RU95112537/04A patent/RU2160736C2/ru active
- 1991-06-06 MC MC91908D patent/MC2210A1/xx unknown
- 1991-06-06 YU YU101091A patent/YU48855B/sh unknown
- 1991-06-06 PL PL91293486A patent/PL166214B1/pl unknown
- 1991-06-06 KR KR1019920700284A patent/KR100215627B1/ko not_active IP Right Cessation
- 1991-06-06 DE DE69127260T patent/DE69127260T2/de not_active Expired - Lifetime
- 1991-06-06 CZ CS19911727A patent/CZ288351B6/cs not_active IP Right Cessation
- 1991-08-05 SA SA05260104A patent/SA05260104B1/ar unknown
-
1992
- 1992-02-06 NO NO920494A patent/NO300634B1/no not_active IP Right Cessation
- 1992-02-06 FI FI920503A patent/FI105686B/fi not_active IP Right Cessation
- 1992-06-25 MX MX9203421A patent/MX9203421A/es unknown
-
1993
- 1993-03-15 LT LTIP419A patent/LT3264B/lt not_active IP Right Cessation
- 1993-06-30 LV LVP-93-872A patent/LV10274B/xx unknown
-
1994
- 1994-09-14 HR HRP-1010/91A patent/HRP940524B1/xx not_active IP Right Cessation
- 1994-12-05 US US08/341,206 patent/US5466699A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/471,229 patent/US5863935A/en not_active Expired - Lifetime
- 1995-06-29 HU HU95P/P00532P patent/HU211479A9/hu unknown
- 1995-07-21 IL IL11469095A patent/IL114690A0/xx unknown
-
1996
- 1996-01-12 FI FI960155A patent/FI106262B/fi not_active IP Right Cessation
-
1997
- 1997-09-24 GR GR970402466T patent/GR3024828T3/el unknown
- 1997-11-07 HK HK97102131A patent/HK1000534A1/xx not_active IP Right Cessation
-
1998
- 1998-01-06 NL NL980001C patent/NL980001I2/nl unknown
- 1998-01-21 NO NO1998005C patent/NO1998005I1/no unknown
- 1998-01-28 LU LU90205C patent/LU90205I2/fr unknown
-
2000
- 2000-06-13 FI FI20001406A patent/FI20001406A/fi unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0486666T3 (da) | Terapeutisk heterocykliske forbindelser | |
FI102069B (fi) | Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi | |
ATE140003T1 (de) | 1,8-naphthyridin-2-on-derivate | |
BG98124A (en) | Active pyrrole-(2,3-)pyridine derivatives | |
FI944823A (fi) | Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa | |
DE69311118T2 (de) | Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung | |
GB1424450A (en) | Isoindoline intermediates | |
ES2088903T3 (es) | Nuevos inhibidores de la s-adenosilmetionina descarboxilasa. | |
ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. |